“Breast cancer research is making a serious headway in its quest to find ways to prevent the disease. New drug therapies may help save millions of lives.”
One out of every eight women in the world battles with breast cancer during her lifetime. It is the second leading cause of cancer-related deaths among women in the United States. Causes of breast cancer remain unknown, and its symptoms show up late in many cases. As the age increases, the risk of breast cancer increases in women. But there are new breakthroughs in medical research and there is renewed hope of a cure that can save millions of lives.
Biphosphonates May Prevent Breast Cancer
Biphosphonates are commonly used drugs to treat osteoporosis. A study funded by the U.S. National Institute of Health (NIH) has revealed that these drugs may inhibit the growth of breast cancer cells. The study found out in its research sample of about 3,000 women that the ones who had used biphosphonates for the maximum period of time cut down their breast cancer risk by nearly two-fifths. However, this result was observed only in women who did not suffer from obesity.
There have been positive reactions to the study from other cancer research organizations in Europe. However, most leading researchers are of the opinion that these findings need to be made more conclusive with more detailed testing in women who are at a higher risk of the disease.
New Preventive Drug in the Pipeline
The Scottish Funding Council and Breakthrough Breast Cancer funded a study conducted by researchers at University of Edinburg that may lead to the development of a new drug. The drug may help to prevent breast cancer in about 20 percent of the patients. About half the breast cancer tumors are known to produce C35 protein, which is suspected to one of the causes of breast cancer.
The new research is working on some chemical agents that may prevent the production of C35 protein. The test results in their initial stages have been positive, but the formulation of a drug for human consumption is still some time away. It is critical to reach a chemical agent that works without causing any harm to the human body, which is the main thrust of the research.
Vaccine to Prevent Breast Cancer
Scientists at Cleveland Clinic’s Lerner Institute in Ohio have made a path-breaking discovery that may finally result in a preventive vaccine against breast cancer. The vaccine that has been in developmental stages for nearly one decade has finally achieved success in preventing the disease in a test group of mice. In addition to preventing the disease, the vaccine also worked to remove the existing tumors in the mice.
Cleveland Clinic is gearing up to seek clearance from the regulatory authorities for human trials of the vaccine. The preventive vaccine would be aimed at all women over the age of 40. Nature Medicine journal has reported the findings of this research with personal interviews of the Cleveland Clinic research team.
Read on
What’s Wrong With Breast Cancer Awareness Month
October is Breast Cancer Awareness Month, which again fills the stores with pink products and pink ribbons. But many people with breast cancer are feeling exploited.
Drug to Combat Breast Cancer in African-American Women
Scientists at Northwestern University experimented with a combination of anti-cancer drug therapy called arsenic trioxide with nanotechnology, which has resulted in new drug with positive results against a specific type of breast cancer. This is a highly aggressive breast cancer known as triple negative, which has a high prevalence among African-American women.
This cancer spreads rapidly and usually the patient has low chances of survival. However, the new drug therapy uses nanotechnology to send arsenic through the blood without letting the body be harmed. Arsenic gets directly delivered to the cancerous cells, and avoids the healthy cells. So the new delivery mechanism has led to a new hope not just for breast cancer, but for several other types of cancer as well.
Fish Oil Supplements May Help to Prevent Breast Cancer
The Journal of Cancer, Epidemiology, Biomarkers and Prevention has published the results of a new study that shows the positive effect of fish oils in prevention of breast cancer. The extensive 6-year study involving over 35,000 women, conducted by researchers at Fred Hutchinson Cancer Research Center in Seattle, has indicated that fish oil supplements can reduce the breast cancer risk among post-menopausal women by about one-third.
The research believes its findings are interesting, but further research is essential to arrive at any conclusive judgment that fish oil is actually responsible for prevention of this disease. Fish oil may help to reduce inflammation in the breast cells, which in turn may prevent the cells from becoming cancerous.
Sources:
Cancer.gov “Breast Cancer” (Accessed on July 17, 2010)
Nlm.nih.gov “Breast Cancer” (Accessed on July 17, 2010)
BreastCancer.Org “Research News” (Accessed on July 17, 2010)
Want to Live an Extra Thousand Years?
read more
IBM jointly, MD, and researchers start date 100 million U.S. dollars of research projects
IBM today announced that the company plans a number of companies recruiting top scientific Dell Inspiron 9300 Battery and technical personnel to help medical staff to patients and insurance companies to provide high quality, evidence-based health care services. As part of the project, IBM is employing a number of medical doctor and the scientists working together for the health and insurance organizations to develop new technologies and research and development, to improve their business processes.
The project is expected to invest the next three years 100 million U.S. dollars of special funds, and the use of IBM systems integration, services, research, cloud computing, analysis and emerging (such as nanotechnology medicine, and computational biology) the areas of leading-edge technology to drive Yi Liao innovation, and help doctors to more of their focus on patient care work.
More than 100 global nine from IBM Research and located in Melbourne, Australia and Taiwan, including Taipei and other areas of joint research institute scientists and researchers have devoted themselves to the project into. As part of the project, IBM want to hire a number of physicians, clinicians, nurses, engineers, economists and social scientists involved. In addition, the company will be looking for new and business, government and university joint research between the partners. IBM will mainly focus on the following three areas:
produce evidence that the use of scientific method to medical data into the original effective medical evidence, after the nursing process in accordance with specific environmental and personal circumstances, use the evidence to treat patients;
simplify the health care delivery processes, improve service quality;
new incentives and model, the health care system into a patient-based outcomes and health status of the system to reward, not just a system to provide treatment and care.
With this new research project, the patient data privacy and security issues will be properly handled, and with the current line of medical and regulatory requirements.
IBM Institute for Medical Chalapathy Neti, global head of restructuring said: “Improving health care quality requires more than just the number of medical data. In fact, the surge in many diagnostic techniques have increased complexity, which we obtained in the field of health care has value things more difficult. to promote the cooperation between medical institutions, medical data into clinical decision-making of intelligent instruments, will greatly improve the treatment effect of patients, reduce the current Acer Aspire 1680 battery cost of medical services. “
Promote the adoption of medical evidence
Today, early diagnosis (to detect the disease and identify potential health risks test) can be the treatment of patients with early stages of intervention for clinicians to provide much information. Obtained from these tests the original data, can be converted to “medical evidence” or clinicians important information needed. As time moves on, the situation of accumulation of digital information, doctors must be able to comprehensive analysis of such large amounts of data from different sources. These data include: patient demographic data, laboratory tests, electrocardiogram (EKG), echo the treatment of graphics, data, and physician recommendations. Medical use of these data can be informed of the overall disease situation in order to make more informed treatment of judgments and decisions.
IBM researchers around the world to cooperate in various fields, in order to bring more evidence-based patient-based treatment. Current research areas include:
computer scientists and cardiologists work together to create a new system, the system can help identify patients with symptoms of the body difficult to identify patterns and characteristics, the diagnosis, comparing results of different treatments and the final results, provide more in-depth insight.
research officer with the European super-gene associations (European HYPERGENES consortium) to cooperate in a unified disease by Gou Jian view and a comprehensive genetic epidemiological models, the genome contribute to enhancing the accuracy of the factors Zhenduan are taken into account to be identified the blood pressure and organ damage associated with genetic variation for individual patients with hypertension introduced a early detection, prevention and treatment of the latest strategy.
When patients with chronic diseases taking multiple medications, and the global aging population to the health care system to new challenges and increase the burden. IBM’s scientists and mathematicians are using data mining, information management and advanced analysis capabilities to build a more easily understood and can be resolved and the role of adverse drug reaction systems to physicians and patients to provide reference to guide them way deal with the disease.
In China, IBM and the Beijing University People’s Hospital created a treatment based on clinical evidence-based medicine solutions. The program concerns the treatment of chronic diseases, integrated management, including patient health, the best practice of medical diagnosis, treatment, and more view of the field, to make clinical decisions for the doctors to provide a strong support.
scientists combining nanotechnology and biology of deep expertise, developed for the latest application of personalized medicine. Researchers have begun looking to the future development of medical diagnostic tests to provide rapid SONY VGP-BPS9 battery and precise analysis of biological samples, testing of various diseases. IBM is also collaborating with the Swiss company Roche to jointly develop technology based on nano-holes quickly and effectively read the human DNA and its sequencing, resulting in more personalized ways of diagnosis and treatment.
Improve service quality, create a new incentive model
Although the treatment has been improved, but the relationship between people and insurance companies still obstacles, and there are problems in many areas. Evolving standards and safety requirements, making the relationship between patients and insurance companies become more complex, cost tracking and management decision-making becomes more difficult. Health care providers, doctors and nurses should work closely to improve service efficiency, improve medical safety, led to the creation of new service models, to promote patient-centered services, which should not only focus on the care. To achieve this goal, IBM’s own application possess the knowledge and business process transformation to provide high quality service experience, to improve the existing health care services.
For example, IBM and National Accounts Service Company (NASCO) to cooperate, to help the company’s welfare and operations teams quickly and accurately with the claims process rules to make changes, rapid response to evolving norms, policies and patients margin rules, on a regular basis with medical benefits synchronization scheme. These changes are very complex and small changes everywhere will bring the results of a series of accidents that may make effective health care claims was denied, or the amount of compensation and error situation. IBM and NASCO together by examining the existing payment norms and rules of the ideas with the industry and the structure of the corresponding comparison in order to achieve Peifu traceability scheme. The team has invented a different code sequences can be translated into English, the technology to analyze these sequences, the similarity of the functional group, and use the data visualization methods show the translated code. Use of IBM in the analysis of complex, large-scale IT systems expertise, the scientists for the NASCO offers a way to improve research methods of payment claims, while improving flexibility, you can on the new or changed regulations and market demands of medical make an effective response.
With in-depth analysis and mathematical analysis of optimization technology, IBM researchers are exploring the best practices based on the payment mode, the patient level, positive results, the level of health of a large-scale population analysis. These efforts can accelerate the process of converting the existing health care system, pay the service charge from a current mode switch to encourage disease prevention and health patterns.
IBM’s research staff research work over the years has been committed to a wide range of sources to collect and link, and these data were analyzed, so that governments, businesses and individuals for greater understanding of what initiatives will enhance the level of human health. Through advanced modeling and simulation technology, the team investigated and simulated in agriculture, transport, urban planning, food and exercise habits, socioeconomic status, family life and more causal relationship between factors in order to determine what type we need incentives or investment, and how to arrange the priorities between them.
IBM using its own scientific and technological achievements and medical HP pavilion ze4400 Battery companies to promote the progress of medical and health history can be traced back to the 20th century 50s. In the last 10 centuries, IBM and Scripps Research Institute to cooperate, in-depth understanding of how the pandemic virus mutation; also cooperate with European universities to develop better HIV antiretroviral therapy and the World Community Grid (World Community Grid), and completed a number of the cancer, AIDS and dengue fever, the medical breakthrough innovative projects.
Want to Live an Extra Thousand Years?
read more
